Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies.
African descent children
Afro-Caribbean children
Auto-immune myositis
Juvenile dermatomyositis
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
07 Oct 2023
07 Oct 2023
Historique:
received:
02
08
2023
accepted:
30
09
2023
medline:
9
10
2023
pubmed:
8
10
2023
entrez:
7
10
2023
Statut:
epublish
Résumé
The epidemiology of Juvenile Dermatomyositis (JDM) in non-Caucasian population is poorly described. We performed a study of patients followed up in the French West Indies for JDM. We aimed to describe clinical and biological specificities during childhood. Retrospective study covering the period from Januarys 2000-2023. Listings of patients were obtained from multiple sources, namely computerized hospital archives, registry of referent pediatricians and adult specialists in internal medicine and the French National Registry for rare diseases. JDM and organ involvement were defined according to the international ILAR criteria. Twenty-one patients were included over a 23 year-period. Median age at onset was 8.1 years (Range: 2.5-13.9) with a median follow up of 8 years (Range: 2-19). Two-thirds (14/21) had dysphagia at onset and 33% had respiratory involvement. Thirteen had specific autoantibodies (58%), most frequently anti-Mi-2. The median number of flares during childhood was three (1-9). During childhood, 76% had calcinosis lesions. Clinical evolution seemed to be more aggressive for boys than girls (respectively 4.2 versus 2.2 flares (p = 0.04) and 50% vs 18% needing more than one background therapy, p = 0.03). This retrospective study is the largest cohort of pediatric patients of Afro-Caribbean and Black African descent treated for JDM in a high-income health system, and the first to describe the incidence and immunological profile in a population of African descent. They had higher rate of calcinosis and similar respiratory involvement. Overall outcomes during childhood were similar to North America and European countries.
Identifiants
pubmed: 37805487
doi: 10.1186/s12969-023-00904-w
pii: 10.1186/s12969-023-00904-w
pmc: PMC10559605
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Clin Exp Rheumatol. 2011 Jan-Feb;29(1):117-24
pubmed: 21345298
Pediatr Rheumatol Online J. 2014 Jan 07;12:2
pubmed: 24397895
Arthritis Care Res (Hoboken). 2014 Mar;66(3):404-10
pubmed: 23983017
Pediatr Rheumatol Online J. 2016 Nov 11;14(1):60
pubmed: 27835954
Pediatr Rheumatol Online J. 2013 Sep 14;11(1):33
pubmed: 24034206
Ann Rheum Dis. 2017 Dec;76(12):1955-1964
pubmed: 29079590
Semin Arthritis Rheum. 2021 Feb;51(1):175-191
pubmed: 33383294
J Rheumatol. 1998 Jun;25(6):1198-204
pubmed: 9632086
Pediatr Rheumatol Online J. 2022 Nov 16;20(1):98
pubmed: 36384585
J Am Acad Dermatol. 2020 Feb;82(2):267-281
pubmed: 31279808
Pediatr Rheumatol Online J. 2022 Nov 12;20(1):95
pubmed: 36371201
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Mod Rheumatol. 2020 May;30(3):411-423
pubmed: 31955618
Arthritis Rheum. 2003 Jun 15;49(3):300-5
pubmed: 12794783
Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):63-72
pubmed: 20191492
Pediatr Rheumatol Online J. 2017 Jan 31;15(1):7
pubmed: 28143550
J Pediatr. 2017 May;184:38-44.e1
pubmed: 28410093
Rheumatology (Oxford). 2006 Oct;45(10):1255-60
pubmed: 16567354